ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

10,706.00
-36.00 (-0.34%)
Last Updated: 11:51:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -36.00 -0.34% 10,706.00 10,706.00 10,708.00 10,780.00 10,700.00 10,756.00 273,975 11:51:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 27.87 165.96B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 10,742p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,390.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £165.96 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 27.87.

Astrazeneca Share Discussion Threads

Showing 6101 to 6123 of 6125 messages
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older
DateSubjectAuthorDiscuss
27/3/2024
15:46
Much more like it today. Plenty of good news lately.
philanderer
21/3/2024
22:16
You're a bit of a one trick pony aren't you!
mattboxy
21/3/2024
08:47
Money moving to APH [LSE] , excellent profitable healthcare company
blackhorse23
19/3/2024
08:50
Wonder how many Fusion Pharm shareholders were relatively new and benefitted from the 97% premium to 18th March close!

Bound to have been plenty of insider dealing stateside, probably in "Options" to leverage the benefit.

Under the terms of the definitive agreement, AstraZeneca, through a subsidiary, will acquire all of Fusion's outstanding shares pursuant to a plan of arrangement for a price of $21.00 per share in cash at closing plus a non-transferable contingent value right of $3.00 per share in cash payable upon the achievement of a specified regulatory milestone. The upfront cash portion of the consideration represents a transaction value of approximately $2bn, a 97% premium to Fusion's closing market price of $10.64 on 18th March 2024 and an 85% premium to the 30-day volume-weighted average price (VWAP) of $11.37 before this announcement.

geckotheglorious
19/3/2024
07:51
A billion dollar deal last week and a two billion dollar deal today….Mr Soriot is investing for the future….that is where the divi increase is being diverted to.
1jat
04/3/2024
15:26
They bought one in early phase development in November:

hxxps://www.astrazeneca.com/media-centre/press-releases/2023/agreement-with-eccogene-for-clinical-stage-glp-1ra.html

andygibb101
01/3/2024
13:14
It's a shame Astra did not have the fat buster drug, Novo Nordisk and EJ Lily gone through the roof.
montyhedge
27/2/2024
08:15
Astra has an IR day in May where they are expected to try to talk up their longer term growth potential
smcni1968
21/2/2024
14:26
Money moving to APH , excellent growth health care company
blackhorse23
21/2/2024
10:55
philanderer - a suggestion
The link does work if you delete everything after "html" - otherwise it seems to stretch the page.

mirandaj
21/2/2024
00:19
"The £135m man: That's how much Pascal Soriot has been paid in 12 years at AstraZeneca... with more to come"
philanderer
20/2/2024
09:46
Berenberg cuts AstraZeneca price target to 12,000 (12,500) pence - 'buy'
philanderer
20/2/2024
00:23
MARKET REPORT: Lung cancer drug gives AstraZeneca a shot in arm
philanderer
19/2/2024
15:03
Hopefully the US investors will get this moving up tomorrow
smcni1968
19/2/2024
10:09
#987. Novo will need to use its new cash flows to diversify.
alphorn
19/2/2024
10:06
Today's news good for the company and good for patients.
alphorn
14/2/2024
09:04
Novo Nordisk the pharma to be in and Glaxo looking good.
montyhedge
12/2/2024
17:26
Market report

"...AstraZeneca shares came into the week on a three-day losing streak, including a more than 6% slide on the day it released annual results.

"‘We think this presents a compelling entry point for a best-in-class company,’ analysts at Barclays said on Monday, however."


sharesmagazine.co.uk

philanderer
12/2/2024
16:22
Don't tell me you sold these to buy APH as well! If APH are so good you should follow your own advice and put all your eggs in that creaky basket.
mattboxy
12/2/2024
16:13
Ex div on the 22nd, may pick up some before then.
chc15
12/2/2024
15:48
24 month low for the shareprice.

Chartwise, support at 8300p

philanderer
12/2/2024
11:50
Blackhorse. No it isn't. Grow up.
tday
12/2/2024
11:37
Money moving to APH
blackhorse23
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older

Your Recent History

Delayed Upgrade Clock